Skip to main content
. 2022 Jan 28;12:813587. doi: 10.3389/fphar.2021.813587

TABLE 4.

Risk stratification by predicted genetic or environmental risk score for cholelithiasis at baseline.

Regular use of PPI Regular use of H2RA
Cases Person-years Incidence rate a HR (95%CI) b RD (95%CI) b Cases Person-years Incidence rate a HR (95%CI) b RD (95% CI) b
Stratified analysis by genetic risk score
 Q1 455 114,981 3.96 1.32 (1.16,1.50) 3.28 (2.32, 3.71) 66 23,634 2.79 0.93 (0.72,1.20) -1.42 (-11.7, 1.93)
 Q2 531 118,062 4.50 1.29 (1.14,1.45) 3.56 (2.39, 4.10) 93 24,988 3.72 1.13 (0.91,1.40) 1.92 (-2.44, 3.32)
 Q3 568 113,913 5.00 1.34 (1.20,1.50) 4.16 (3.26, 4.63) 120 24,772 4.84 1.31 (1.08,1.59) 3.92 (1.68, 4.64)
 Q4 690 115,525 6.00 1.16 (1.04,1.28) 3.34 (1.11, 4.55) 151 25,490 5.92 1.23 (1.04,1.46) 4.10 (1.10, 5.36)
P interaction 0.223 0.337 0.15 0.288
Stratified analysis by environmental risk score
 Q1 21 17,533 1.20 1.49 (0.95, 2.32) 1.15 (-0.48, 1.2) 7 9,058 0.77 0.92 (0.4, 2.07) -0.6 (-56.18, 0.77)
 Q2 131 47,353 2.77 1.65 (1.35, 2.01) 2.71 (2.41, 2.76) 38 14,558 2.61 1.62 (1.16, 2.25) 2.55 (1.60, 2.61)
 Q3 353 110,383 3.20 1.31 (1.16, 1.49) 2.66 (1.92, 3.01) 80 25,467 3.14 1.2 (0.95, 1.51) 2.15 (-1.05, 2.98)
 Q4 1759 290,297 6.06 1.22 (1.15, 1.31) 4.09 (3.24, 4.81) 308 50,404 6.11 1.14 (1.01, 1.28) 3.12 (0.30, 4.64)
P interaction 0.068 <0.001 0.362 0.926
Stratified analysis by environmental and genetic risk score
 Q1 29 21,036 1.38 1.72 (1.16, 2.55) 1.37 (0.90, 1.38) 6 9,422 0.64 0.92 (0.41, 2.07) -0.51 (-48.31, 0.64)
 Q2 134 53,495 2.51 1.72 (1.16, 2.55) 2.47 (1.54, 2.50) 35 15,704 2.23 1.43 (1.01, 2.03) 2.07 (0.13, 2.22)
 Q3 375 113,935 3.29 1.34 (1.18, 1.52) 2.82 (2.12, 3.12) 96 25,483 3.77 1.42 (1.15, 1.76) 3.41 (2.14, 3.71)
 Q4 1706 274,015 6.23 1.23 (1.15, 1.31) 4.29 (3.32, 4.94) 293 48,274 6.07 1.1 (0.97, 1.24) 2.43 (-1.00, 4.29)
 P interaction 0.191 <0.001 0.176 0.237
a

Per 100,000 person years.

b

Estimated effects were based on the fully adjusted model (see the footnote in Table 2).